EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Critical Analysis of Thrombocytopenia Associated With Glycoprotein IIb/IIIa Inhibitors and Potential Role of Zalunfiban, a Novel Small Molecule Glycoprotein Inhibitor, in Understanding the Mechanism(s)

Sem A O F Rikken iD, Arnoud W J van 't Hof iD, Jurriën M Ten Berg iD, Dean J Kereiakes iD, Barry S Coller iD

Journal of the American Heart Association · 19.12.2023 · 12 (24)

DOI: 10.1161/jaha.123.031855 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the American Heart Association, erschienen am 19.12.2023. Verfasst von Sem A O F Rikken und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology St. Antonius Hospital Nieuwegein The Netherlands. Hauptthemen laut MEDLINE: Platelet Aggregation Inhibitors, Thrombocytopenia. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thrombocytopenia is a rare but serious complication of the intravenous glycoprotein IIb/IIIa (GPIIb/IIIa; integrin αIIbβ3) receptor inhibitors (GPIs), abciximab, eptifibatide, and tirofiban. The thrombocytopenia ranges from mild (50 000–100 000 platelets/μL), to severe (20 000 to

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet Aggregation InhibitorsThrombocytopeniaHumansAbciximabPlatelet Glycoprotein GPIIb-IIIa ComplexAntibodies, MonoclonalImmunoglobulin Fab FragmentsTyrosine

Stichwörter der Autor:innen

abciximabeptifibatidethrombocytopeniatirofibanzalunfiban

Substanzen

AbciximabPlatelet Aggregation InhibitorsPlatelet Glycoprotein GPIIb-IIIa ComplexAntibodies, MonoclonalImmunoglobulin Fab FragmentsTyrosine

Autor:innen und Institutionen

  • Department of Cardiology St. Antonius Hospital Nieuwegein The Netherlands.
  • Cardiovascular Research Institute Maastricht (CARIM) Maastricht The Netherlands.
  • Department of Cardiology MUMC+ Maastricht The Netherlands.
  • Department of Cardiology Zuyderland Medical Centre Heerlen The Netherlands.
  • The Christ Hospital Heart and Vascular Institute and Lindner Clinical Research Center Cincinnati OH USA.
  • Allen and Frances Adler Laboratory of Blood and Vascular Biology Rockefeller University New York NY USA.

ORCID-Profile: Sem A O F Rikken, Arnoud W J van 't Hof, Jurriën M Ten Berg, Dean J Kereiakes, Barry S Coller

Förderung

  • NHLBI NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Rikken, S. A. O. F., van 't Hof, A. W. J., Ten Berg, J. M., Kereiakes, D. J., & Coller, B. S. (2023). Critical Analysis of Thrombocytopenia Associated With Glycoprotein IIb/IIIa Inhibitors and Potential Role of Zalunfiban, a Novel Small Molecule Glycoprotein Inhibitor, in Understanding the Mechanism(s). Journal of the American Heart Association, 12(24). https://doi.org/10.1161/jaha.123.031855

Vancouver

Rikken SAOF, van 't Hof AWJ, Ten Berg JM, Kereiakes DJ, Coller BS. Critical Analysis of Thrombocytopenia Associated With Glycoprotein IIb/IIIa Inhibitors and Potential Role of Zalunfiban, a Novel Small Molecule Glycoprotein Inhibitor, in Understanding the Mechanism(s). Journal of the American Heart Association. 2023;12(24). doi:10.1161/jaha.123.031855

BibTeX
@article{Rikken2023,
  author = {Rikken, Sem A O F and van 't Hof, Arnoud W J and Ten Berg, Jurriën M and Kereiakes, Dean J and Coller, Barry S},
  title = {Critical Analysis of Thrombocytopenia Associated With Glycoprotein IIb/IIIa Inhibitors and Potential Role of Zalunfiban, a Novel Small Molecule Glycoprotein Inhibitor, in Understanding the Mechanism(s)},
  journal = {Journal of the American Heart Association},
  year = {2023},
  volume = {12},
  number = {24},
  doi = {10.1161/jaha.123.031855}
}
Kostenlos starten →